Advanced Glycation End Products and Cardiovascular Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6417|4|2|92-100

ISSN： 1573-3998

Source： Current Diabetes Reviews, Vol.4, Iss.2, 2008-05, pp. : 92-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 236-240

Bentham Science Publishers

Access to resources Recommend Favorite

Basic and Clinical Research Against Advanced Glycation End Products (AGEs): New Compounds to Tackle Cardiovascular Disease and Diabetic Complications

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 10, Iss. 1, 2015-04 ,pp. : 10-33

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Renin-Angiotensin System and Advanced Glycation End Products Formation: A Promising Therapeutic Approach Targeting on Cardiovascular Diseases

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 4, 2007-01 ,pp. : 249-264

Bentham Science Publishers

Access to resources Recommend Favorite

Scavenger Receptors that Recognize Advanced Glycation End Products

By Miyazaki A.   Nakayama H.   Horiuchi S.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 6, 2002-08 ,pp. : 258-262

Elsevier

Access to resources Recommend Favorite

Advanced Glycation End Products and Acute Myocardial Infarction

By  

Medical Principles and Practice, Vol. 19, Iss. 3, 2010-03 ,pp. : 244-246

Karger

Access to resources Recommend Favorite